```html

Yellow Plaque on Skin (Xanthomas)

What is Yellow plaque on skin (xanthomas)?

Xanthomas are firm, yellow‑colored plaques or nodules that develop in the skin or tendons when excess cholesterol or other lipids accumulate in the tissue. The word “xanthoma” comes from the Greek xanthos, meaning “yellow.” Although they are usually harmless in appearance, xanthomas are often a visible sign of an underlying metabolic or systemic disorder, especially disorders of lipid metabolism.

These lesions can vary in size from a few millimeters to several centimeters, and they may appear singly or in clusters. Common locations include the elbows, knees, hands, feet, buttocks, eyelids (known as xanthelasma), and the tendons of the hands (tendon xanthoma). Because they are visible on the skin’s surface, xanthomas are frequently the first clue that prompts a medical evaluation.

Common Causes

Most xanthomas are linked to high levels of cholesterol or triglycerides in the blood, but they can also arise from other conditions. The most frequent causes are:

• Familial Hypercholesterolemia (FH): An inherited disorder causing very high LDL‑cholesterol from birth.
• Familial Hypertriglyceridemia: Elevated triglycerides, often leading to eruptive xanthomas.
• Combined (Mixed) Hyperlipidemia: Both cholesterol and triglycerides are elevated.
• Primary Bile‑Acid Disorders (e.g., Cholestatic Liver Disease): Bile flow obstruction leads to xanthomas, especially on the palms and soles.
• Type IIa, IIb, III, IV, V Dyslipidemias: Classified by the Fredrickson system, each pattern has characteristic skin findings.
• Secondary Lipid Elevations: Diabetes mellitus, hypothyroidism, nephrotic syndrome, or medications such as corticosteroids and retinoids.
• Monoclonal Gammopathies: Conditions like multiple myeloma can cause “xanthoma-like” lesions called “cholesterol granulomas.”
• Systemic Lupus Erythematosus (SLE) & Other Autoimmune Diseases: Occasionally associated with xanthoma formation.
• Dietary Causes: Very high intake of saturated fats or cholesterol can exacerbate existing lipid disorders.
• Rare Genetic Syndromes: such as sitosterolemia (plant sterol accumulation) or Anderson‑Fabry disease.

Associated Symptoms

While the plaques themselves are often painless, they may be accompanied by other signs that hint at the underlying cause:

• Fatigue or weakness (common in uncontrolled hyperlipidemia).
• Chest pain or shortness of breath – possible early coronary artery disease.
• Abdominal pain, especially in pancreatitis secondary to severe hypertriglyceridemia.
• Yellowing of the eyes (jaundice) in cholestatic liver disease.
• Swelling of the legs or ankles (edema) in nephrotic syndrome.
• Weight loss or gain, polyuria, and polydipsia in uncontrolled diabetes.
• Family history of early‑onset heart attacks or strokes.

When to See a Doctor

Because xanthomas can be the first sign of a serious metabolic condition, you should schedule an evaluation promptly if you notice any of the following:

• New yellow plaques that appear suddenly or increase in size.
• Multiple lesions appearing on the hands, feet, elbows, or eyelids.
• Any personal or family history of high cholesterol, heart attack before age 55 (men) or 65 (women), or stroke.
• Symptoms of heart disease (chest pain, palpitations, shortness of breath).
• Signs of pancreatitis (severe upper‑abdominal pain radiating to the back, nausea, vomiting).
• Unexplained swelling, foamy urine, or rapid weight changes.

Diagnosis

Evaluation of xanthomas typically involves a combination of visual assessment, laboratory testing, and sometimes imaging.

1. Clinical Examination

• Dermatologic inspection – location, size, number, and texture of plaques.
• Palpation – most xanthomas feel firm but not hard, and they are generally non‑tender.

2. Laboratory Tests

• Lipid panel: Total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Liver function tests (LFTs): ALT, AST, alkaline phosphatase, bilirubin – to detect cholestasis.
• Renal function: Serum creatinine, urine protein/creatinine ratio – evaluates nephrotic syndrome.
• Thyroid panel: TSH and free T4 – hypothyroidism can raise cholesterol.
• For suspicious secondary causes, additional tests (e.g., fasting glucose, HbA1c, autoimmune panels) may be ordered.

3. Imaging & Specialized Studies

• Ultrasound or CT scan of abdomen: When a cholestatic liver disease is suspected.
• Coronary calcium scoring or stress testing: To evaluate cardiovascular risk in high‑risk patients.
• Skin biopsy (rarely needed): Histology shows lipid‑laden macrophages (foam cells) confirming a xanthoma.

4. Genetic Testing

If familial hypercholesterolemia or a rare lipid disorder is suspected, genetic panels can identify pathogenic variants in LDLR, APOB, PCSK9, or other relevant genes.<sup>1</sup>

Treatment Options

Therapy focuses on two goals: (1) removing or reducing the visible plaques and (2) correcting the underlying metabolic abnormality.

1. Lifestyle Modifications

• Heart‑healthy diet: Emphasize fruits, vegetables, whole grains, legumes, lean protein, and fish rich in omega‑3 fatty acids. Limit saturated fat (<7% of total calories), trans fats, and dietary cholesterol.
• Weight management: Losing 5–10% of body weight can improve LDL‑C and triglycerides.
• Physical activity: At least 150 minutes of moderate‑intensity aerobic exercise per week (e.g., brisk walking, cycling).
• Alcohol moderation: Excess alcohol raises triglycerides dramatically.
• Smoking cessation: Smoking accelerates atherosclerosis and worsens lipid profiles.

2. Medications

• Statins (e.g., atorvastatin, rosuvastatin): First‑line agents that lower LDL‑C by 30‑50% and have proven cardiovascular benefit.
• Ezetimibe: Blocks intestinal cholesterol absorption; useful when statins alone are insufficient.
• PCSK9 inhibitors (evolocumab, alirocumab): Very effective for familial hypercholesterolemia; reduce LDL‑C up to 60%.
• Fibrates (gemfibrozil, fenofibrate): Primarily lower triglycerides and modestly raise HDL‑C; indicated for eruptive xanthomas.
• Niacin: Can lower triglycerides and raise HDL‑C, but side‑effects limit its use.
• Omega‑3 fatty acid formulations (eicosapentaenoic acid): Particularly useful for severe hypertriglyceridemia.
• Bile‑acid sequestrants (cholestyramine, colesevelam): Reduce LDL‑C; useful in patients who cannot tolerate statins.

3. Direct Removal of Skin Lesions

• Laser therapy (e.g., CO₂ or Nd:YAG): Can flatten superficial xanthomas; requires specialist care.
• Surgical excision: Reserved for large or bothersome plaques, especially on the hands or eyelids.
• Cryotherapy: Occasionally used for small eruptive lesions.

4. Management of Underlying Disease

For secondary causes, treating the primary condition often clears the plaques. Examples include:

• Optimizing insulin therapy in uncontrolled diabetes.
• Thyroid hormone replacement in hypothyroidism.
• Immunosuppressive therapy for lupus flare‑ups.
• Effective management of nephrotic syndrome with ACE inhibitors or steroids.

Prevention Tips

While some genetic disorders cannot be prevented, many risk factors for xanthomas are modifiable:

• Get a lipid panel checked at least once every 4–6 years for adults; earlier if you have risk factors (family history, obesity, diabetes).
• Adopt a Mediterranean‑style diet rich in monounsaturated fats, nuts, and fish.
• Stay active; aim for ≥30 minutes of moderate exercise most days.
• Limit sugary beverages and refined carbohydrates that spike triglycerides.
• Maintain a healthy weight; even modest weight loss improves lipid levels.
• Avoid tobacco and limit alcohol consumption.
• If you have a known lipid disorder, adhere strictly to prescribed medication and follow‑up appointments.
• Discuss with your doctor before starting any new supplement (e.g., high‑dose vitamin E, fish oil) because some can affect lipid metabolism.

Emergency Warning Signs

References

1. Stone NJ, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Circulation. 2019;139:e1082‑e1143.
2. Mayo Clinic. Xanthomas – Symptoms and Causes. https://www.mayoclinic.org
3. Cleveland Clinic. Familial Hypercholesterolemia: Diagnosis and Treatment. https://my.clevelandclinic.org
4. American Heart Association. Understanding Triglycerides. https://www.heart.org
5. National Institute of Diabetes and Digestive and Kidney Diseases. Hypertriglyceridemia. https://www.niddk.nih.gov
6. World Health Organization. WHO Guidelines on Diet, Physical Activity and Health. 2020.

```